15388 results for "1 mil coins fc 26 Visit Buyfc26coins.com for latest FC 26 coins news..buoc"

in 55.99 milliseconds.

• Reference epigenome SMC05 h3k27ac ChIP-Seq data generated from KEP study

  SMC05 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007332

• Reference epigenome SMC05 h3k36me3 ChIP-Seq data generated from KEP study

  SMC05 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007333

• Reference epigenome SMC05 h3k4me1 ChIP-Seq data generated from KEP study

  SMC05 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007334

• Reference epigenome SMC05 h3k4me3 ChIP-Seq data generated from KEP study

  SMC05 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007335

• Reference epigenome Islet-derived-iPSC02 miRNA-Seq data generated from KEP study

  Islet-derived-iPSC02 miRNA-Seq single end data

  Dataset EGAD00001007186

• Reference epigenome ADMSC06 h3k9me3 ChIP-Seq data generated from KEP study

  ADMSC06 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007386

• Reference epigenome ADMSC06 input ChIP-Seq data generated from KEP study

  ADMSC06 input ChIP-Seq paired end data

  Dataset EGAD00001007387

• Reference epigenome ADMSC07 h3k27Ac ChIP-Seq data generated from KEP study

  ADMSC07 h3k27Ac ChIP-Seq paired end data

  Dataset EGAD00001007388

• Reference epigenome ADMSC07 h3k27me3 ChIP-Seq data generated from KEP study

  ADMSC07 h3k27me3 ChIP-Seq paired end data

  Dataset EGAD00001007389

• Reference epigenome ADMSC07 h3k36me3 ChIP-Seq data generated from KEP study

  ADMSC07 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007390

• Reference epigenome ADMSC07 h3k4me3 ChIP-Seq data generated from KEP study

  ADMSC07 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007392

• Reference epigenome ADMSC07 h3k9me3 ChIP-Seq data generated from KEP study

  ADMSC07 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007393

• Reference epigenome ADMSC07 input ChIP-Seq data generated from KEP study

  ADMSC07 input ChIP-Seq paired end data

  Dataset EGAD00001007394

• Reference epigenome ADMSC08 h3k27Ac ChIP-Seq data generated from KEP study

  ADMSC08 h3k27Ac ChIP-Seq paired end data

  Dataset EGAD00001007395

• Reference epigenome ADMSC08 h3k27me3 ChIP-Seq data generated from KEP study

  ADMSC08 h3k27me3 ChIP-Seq paired end data

  Dataset EGAD00001007396

• Reference epigenome ADMSC08 h3k36me3 ChIP-Seq data generated from KEP study

  ADMSC08 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007397

• Reference epigenome ADMSC08 h3k4me1 ChIP-Seq data generated from KEP study

  ADMSC08 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007398

• Reference epigenome ADMSC08 h3k4me3 ChIP-Seq data generated from KEP study

  ADMSC08 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007399

• Reference epigenome ADMSC08 h3k9me3 ChIP-Seq data generated from KEP study

  ADMSC08 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007400

• Reference epigenome ADMSC08 input ChIP-Seq data generated from KEP study

  ADMSC08 input ChIP-Seq paired end data

  Dataset EGAD00001007401

• Reference epigenome SMC05 input ChIP-Seq data generated from KEP study

  SMC05 input ChIP-Seq paired end data

  Dataset EGAD00001007337

• Reference epigenome SMC07 h3k27ac ChIP-Seq data generated from KEP study

  SMC07 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007338

• Reference epigenome SMC07 h3k36me3 ChIP-Seq data generated from KEP study

  SMC07 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007339

• Reference epigenome SMC07 h3k4me1 ChIP-Seq data generated from KEP study

  SMC07 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007340

• Reference epigenome SMC07 h3k4me3 ChIP-Seq data generated from KEP study

  SMC07 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007341

• Reference epigenome SMC07 h3k9me3 ChIP-Seq data generated from KEP study

  SMC07 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007342

• Reference epigenome SMC07 input ChIP-Seq data generated from KEP study

  SMC07 input ChIP-Seq paired end data

  Dataset EGAD00001007343

• Reference epigenome SMC08 h3k27ac ChIP-Seq data generated from KEP study

  SMC08 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007344

• Reference epigenome SMC08 h3k36me3 ChIP-Seq data generated from KEP study

  SMC08 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007345

• Reference epigenome SMC08 h3k4me1 ChIP-Seq data generated from KEP study

  SMC08 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007346

• Reference epigenome SMC08 h3k4me3 ChIP-Seq data generated from KEP study

  SMC08 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007347

• Reference epigenome SMC08 h3k9me3 ChIP-Seq data generated from KEP study

  SMC08 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007348

• Reference epigenome SMC08 input ChIP-Seq data generated from KEP study

  SMC08 input ChIP-Seq paired end data

  Dataset EGAD00001007349

• Reference epigenome SMC09 h3k27ac ChIP-Seq data generated from KEP study

  SMC09 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007350

• Reference epigenome SMC09 h3k36me3 ChIP-Seq data generated from KEP study

  SMC09 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007351

• Reference epigenome SMC09 h3k4me1 ChIP-Seq data generated from KEP study

  SMC09 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007352

• Reference epigenome SMC09 h3k4me3 ChIP-Seq data generated from KEP study

  SMC09 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007353

• Reference epigenome SMC09 h3k9me3 ChIP-Seq data generated from KEP study

  SMC09 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007354

• Reference epigenome SMC09 input ChIP-Seq data generated from KEP study

  SMC09 input ChIP-Seq paired end data

  Dataset EGAD00001007355

• Reference epigenome ADMSC01 h3k27ac ChIP-Seq data generated from KEP study

  ADMSC01 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007356

• Reference epigenome ADMSC01 h3k36me3 ChIP-Seq data generated from KEP study

  ADMSC01 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007357

• Reference epigenome ADMSC01 h3k4me1 ChIP-Seq data generated from KEP study

  ADMSC01 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007358

• Reference epigenome ADMSC01 h3k4me3 ChIP-Seq data generated from KEP study

  ADMSC01 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007359

• Reference epigenome ADMSC01 h3k9me3 ChIP-Seq data generated from KEP study

  ADMSC01 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007360

• Reference epigenome ADMSC01 input ChIP-Seq data generated from KEP study

  ADMSC01 input ChIP-Seq paired end data

  Dataset EGAD00001007361

• Reference epigenome ADMSC02 h3k27ac ChIP-Seq data generated from KEP study

  ADMSC02 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007362

• Reference epigenome ADMSC02 h3k36me3 ChIP-Seq data generated from KEP study

  ADMSC02 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007363

• Reference epigenome ADMSC02 h3k4me1 ChIP-Seq data generated from KEP study

  ADMSC02 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007364

• Reference epigenome ADMSC02 h3k4me3 ChIP-Seq data generated from KEP study

  ADMSC02 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007365

• Reference epigenome ADMSC02 h3k9me3 ChIP-Seq data generated from KEP study

  ADMSC02 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007366

• Reference epigenome ADMSC02 input ChIP-Seq data generated from KEP study

  ADMSC02 input ChIP-Seq paired end data

  Dataset EGAD00001007367

• Reference epigenome ADMSC03 h3k27ac ChIP-Seq data generated from KEP study

  ADMSC03 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007368

• Reference epigenome ADMSC03 h3k36me3 ChIP-Seq data generated from KEP study

  ADMSC03 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007369

• Reference epigenome ADMSC03 h3k4me1 ChIP-Seq data generated from KEP study

  ADMSC03 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007370

• Reference epigenome ADMSC03 h3k4me3 ChIP-Seq data generated from KEP study

  ADMSC03 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007371

• Reference epigenome ADMSC03 h3k9me3 ChIP-Seq data generated from KEP study

  ADMSC03 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007372

• Reference epigenome ADMSC03 input ChIP-Seq data generated from KEP study

  ADMSC03 input ChIP-Seq paired end data

  Dataset EGAD00001007373

• Reference epigenome ADMSC05 h3k27Ac ChIP-Seq data generated from KEP study

  ADMSC05 h3k27Ac ChIP-Seq paired end data

  Dataset EGAD00001007374

• Reference epigenome ADMSC05 h3k36me3 ChIP-Seq data generated from KEP study

  ADMSC05 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007376

• Reference epigenome ADMSC05 h3k4me1 ChIP-Seq data generated from KEP study

  ADMSC05 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007377

• Reference epigenome ADMSC05 h3k4me3 ChIP-Seq data generated from KEP study

  ADMSC05 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007378

• Reference epigenome ADMSC05 h3k9me3 ChIP-Seq data generated from KEP study

  ADMSC05 h3k9me3 ChIP-Seq paired end data

  Dataset EGAD00001007379

• Reference epigenome ADMSC05 input ChIP-Seq data generated from KEP study

  ADMSC05 input ChIP-Seq paired end data

  Dataset EGAD00001007380

• Reference epigenome ADMSC06 h3k27Ac ChIP-Seq data generated from KEP study

  ADMSC06 h3k27Ac ChIP-Seq paired end data

  Dataset EGAD00001007381

• Reference epigenome ADMSC06 h3k27me3 ChIP-Seq data generated from KEP study

  ADMSC06 h3k27me3 ChIP-Seq paired end data

  Dataset EGAD00001007382

• Reference epigenome ADMSC06 h3k36me3 ChIP-Seq data generated from KEP study

  ADMSC06 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007383

• Reference epigenome ADMSC06 h3k4me1 ChIP-Seq data generated from KEP study

  ADMSC06 h3k4me1 ChIP-Seq paired end data

  Dataset EGAD00001007384

• Reference epigenome ADMSC06 h3k4me3 ChIP-Seq data generated from KEP study

  ADMSC06 h3k4me3 ChIP-Seq paired end data

  Dataset EGAD00001007385

• Metadata annotation table

  Clinical data from IMblaze370: Clinical data include disease, treatment arm, MSI status, KRAS oncogenic mutation status, sex, and overall survival (1=dead, 0=alive)

  Dataset EGAD00001008551

• Sample sheet

  Sample sheet linking anonymized sample IDs and anonymized patient IDs.

  Dataset EGAD00001011108

• Whole exome sequencing of an invasive diffuse intrinsic pontine glioma sampled from different sites

  The lateral ventricle subventricular zone (SVZ) is a frequent site of high-grade glioma (HGG) spread and tumor invasion of the SVZ is a predictor of a worse clinical prognosis. A range of HGG types invade the stem cell niche of the SVZ, including both adult glioblastoma and pediatric high-grade gliomas such as diffuse intrinsic pontine glioma (DIPG). The cellular and molecular mechanisms mediating this frequent invasion of the SVZ are poorly understood. Here we demonstrate that neural precursor cell (NPC):glioma cell communication underpins the propensity of glioma to colonize the SVZ. SVZ NPCs secrete chemoattractant signals toward which glioma cells home. Biochemical and proteomic analyses of factors secreted by SVZ NPCs revealed a discrete list of candidate proteins. Necessity and sufficiency testing implicated the neurite outgrowth-promoting factor pleiotrophin, along with three required binding partners (secreted protein acidic and rich in cysteine (SPARC), SPARC-like protein 1, and heat shock protein 90B), as key mediators of this chemoattractant effect. Pleiotrophin protein expression is strongly enriched in the SVZ, and knockdown of pleiotrophin expression starkly reduced glioma invasion of the SVZ in the adult murine brain. Pleiotrophin, in complex with the three binding partners, activated the Rho/ROCK pathway in DIPG cells, and inhibition of ROCK resulted in decreased DIPG invasion toward SVZ neural precursor cell-secreted factors. These findings demonstrate a pathogenic role for neural precursor cell – glioma interactions and potential therapeutic targets to limit glioma invasion.

  Study EGAS00001002326

• Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases

  Adrenocortical carcinoma is a rare malignancy with a poor prognosis and few treatment options. Molecular characterization of this cancer remains limited. We present a case of an adrenocortical carcinoma (ACC) in a 37-yr-old female, with dual lung metastases identified 1 yr following commencement of adjuvant mitotane therapy. As standard therapeutic regimens are often unsuccessful in ACC, we undertook a comprehensive genomic study into this case to identify treatment options and monitor disease progress. We performed targeted and whole-genome sequencing of germline, primary tumor, and both metastatic tumors from this patient and monitored recurrence over 2 yr using liquid biopsy for ctDNA and steroid hormone measurements. Sequencing revealed the primary and metastatic tumors were hyperhaploid, with extensive loss of heterozygosity but few structural rearrangements. Loss-of-function mutations were identified in MSH2, TP53, RB1, and PTEN, resulting in tumors with mismatch repair signatures and microsatellite instability. At the cellular level, tumors were populated by mitochondria-rich oncocytes. Longitudinal ctDNA mutation and hormone profiles were unable to detect micrometastatic disease, consistent with clinical indicators of disease remission. The molecular signatures in our ACC case suggested immunotherapy in the event of disease progression; however, the patient remains free of cancer. The extensive molecular analysis presented here could be applied to other rare and/or poorly stratified cancers, to identify novel or repurpose existing therapeutic options, thereby broadly improving diagnoses, treatments, and prognoses.

  Study EGAS00001003497

• SF11940

  SF11940 snATAC Sequencing.Anaplastic Astrocytoma, IDH-mutant. Tumor location: Left Frontal. Age: 29. Sex: Male .

  Dataset EGAD00001006311

• SF10207

  SF10207 snATAC Seq. Oligodendroglioma, Anaplastic (WHO gr. 3). Tumor Location:Frontal. Age:43. Sex: Male

  Dataset EGAD00001006319

• 4C-seq data of a primary AML with t(3;8)

  The viewpoints used in the 4C-seq data were either the EVI1 promoter or the MYC super-enhancer

  Dataset EGAD00001006818

• Reference epigenome Islet-derived-MSC01 mRNA-Seq data generated from KEP study

  Islet-derived-MSC01 mRNA-Seq paired end data

  Dataset EGAD00001007160

• Reference epigenome Islet-derived-MSC02 mRNA-Seq data generated from KEP study

  Islet-derived-MSC02 mRNA-Seq paired end data

  Dataset EGAD00001007161

• Reference epigenome Islet-derived-MSC03 mRNA-Seq data generated from KEP study

  Islet-derived-MSC03 mRNA-Seq paired end data

  Dataset EGAD00001007162

• Reference epigenome Islet-derived-MSC04 mRNA-Seq data generated from KEP study

  Islet-derived-MSC04 mRNA-Seq paired end data

  Dataset EGAD00001007163

• Reference epigenome Islet-derived-iPSC01 mRNA-Seq data generated from KEP study

  Islet-derived-iPSC01 mRNA-Seq paired end data

  Dataset EGAD00001007164

• Reference epigenome Islet-derived-iPSC02 mRNA-Seq data generated from KEP study

  Islet-derived-iPSC02 mRNA-Seq paired end data

  Dataset EGAD00001007165

• Reference epigenome IPS-ENeuron02 h3k27ac ChIP-Seq data generated from KEP study

  IPS-ENeuron02 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007298

• Reference epigenome Pancreas-Islet02 h3k36me3 ChIP-Seq data generated from KEP study

  Pancreas-Islet02 h3k36me3 ChIP-Seq paired end data

  Dataset EGAD00001007195

• Reference epigenome IPS-Fibroblast02 h3k27ac ChIP-Seq data generated from KEP study

  IPS-Fibroblast02 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007270

• Reference epigenome IPS-Fibroblast02 input ChIP-Seq data generated from KEP study

  IPS-Fibroblast02 input ChIP-Seq paired end data

  Dataset EGAD00001007276

• WES from tFL with PMBL GE signature

  Exome sequencing data from transformed Follicular Lymphoma samples that express a PMBL-like gene expression signature

  Dataset EGAD00001008498

• Single Nuclei RNA sequencing batch 1

  This dataset includes the first 9 PTC samples and 6 ATC samples profiled on the same sequencing flowcell.

  Dataset EGAD00001011366

• The Genomics of Pilocytic Astrocytoma Formation in Neurofibromatosis Type 1

  Neurofibromatosis type 1 (NF1) inherited cancer predisposition syndrome is one of the most common autosomal dominant tumor predisposition syndromes in which affected individuals develop brain tumors. These low-grade glial neoplasms (pilocytic astrocytomas) typically arise in children younger than 7 years of age and are hypothesized to result from a combination of germline and acquired somatic NF1 tumor suppressor gene mutations. In this study, whole genome sequence analysis was performed on three NF1-associated pilocytic astrocytoma tumors (NF1-PA) and matched normal blood samples to establish the genomic landscape of NF1-PA. These data support the existence of multiple distinct mechanisms (mutation, LOH, and methylation) underlying somatic NF1 inactivation in NF1-PA tumors.

  Study phs000563

• Genome and transcriptome sequence data from a neurofibromatosis type 1 tumor patient

  Genome and transcriptome sequence data from a neurofibromatosis type 1 patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015301

• 16S rRNA gene amplification and maternal factors

  Human breast milk contains a diverse community of bacteria but factors that produce variation in the breast milk microbiome are largely unknown. We evaluated if 1) maternal factors including breastfeeding practices modified the diversity and abundance of bacterial communities in breast milk and 2) if subclinical mastitis (SCM), an asymptomatic inflammatory condition occurring during lactation, induced a distinctive microbiota signature.

  Study EGAS00001003044

• The_Little_Princess_Knowledge_Bank_RNAseq

  The purpose of the knowledge bank is to serve as a community resource and to address the following specific questions about Wilms tumour: (1) Do genetic, epigenetic, or transcriptional features predict outcome and thus lend themselves to treatment stratification? (2) What are the genetic drivers of Wilms tumour, considering the entire histological spectrum of Wilms tumour including the most common subtypes classified as intermediate risk?

  Study EGAS00001005244

• Whole genome sequencing of UM with MSI

  Illumina platform sequencing of whole genome libraries prepared from paired tumour/normal samples from 1 case of melanoma uveal with MSI

  Dataset EGAD50000001337

• APP-G-1

  Array data from 4778 individuals from general population of rural Uganda

  Dataset EGAD00010000965

• Transcriptome of (peripheral blood), from donor Sample B, replicate 2 time-course biological replicates; 10x lane replicate 3

  time-course biological replicates; 10x lane replicate 3

  Dataset EGAD00001010093

• Transcriptome of (peripheral blood), from donor Sample B, replicate 2 time-course biological replicates; 10x lane replicate 2

  time-course biological replicates; 10x lane replicate 2

  Dataset EGAD00001010091

• OT2_Illumina_RNA_T_CELL

  RNAseq on Illumina HiSeq2000/2500 of PDO culture derived from colorectal cancer primary tumor sample (OT2_cohort)

  Dataset EGAD00001003368

• OT2_Illumina_WGS_MET_CELL

  Whole-genome sequencing on Illumina HiSeq2000/2500 of PDO culture derived from colorectal cancer metastasis sample (OT2_cohort)

  Dataset EGAD00001003373

• OT2_Illumina_WXS_MET_CELL

  Whole-exome sequencing on Illumina HiSeq2000/2500 of PDO culture derived from colorectal cancer metastasis sample (OT2_cohort)

  Dataset EGAD00001003380

• BC WGS Dataset 1

  Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

  Dataset EGAD00001001350

• Transcriptome

  Transcriptome from EGAS00001001845

  Dataset EGAD00001002161